May 24, 2006
20:19
For every 19 shares held, investors received 20. The price per share adjusted from $1430.00 to $1358.50.
The split itself did not change the total investment value.
Hanall Biopharma Co., Ltd. (KRX:009420) operates in the Pharmaceuticals: major industry.
Hanall Biopharma Co., Ltd. company overviewHanall Biopharma Co., Ltd.'s most recent stock split was on May 24, 2006. It was a 20-for-19 forward split, so shareholders received 20 shares for every 19 they held.
Hanall Biopharma Co., Ltd. (KRX:009420) has split its stock 8 times: a 26-for-25 split on January 4, 1993, a 103-for-100 split on January 3, 1994, a 13-for-12 split on April 8, 1994, a 6-for-5 split on May 24, 1994, a 51-for-50 split on January 3, 1995, a 51-for-50 split on January 3, 1996, a 10-for-1 split on May 10, 2006, and a 20-for-19 split on May 24, 2006.
Hanall Biopharma Co., Ltd. has split its stock 8 times. This history records 8 forward splits between January 4, 1993 and May 24, 2006.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Hanall Biopharma Co., Ltd.'s 20-for-19 split on May 24, 2006, every 19 shares became 20 shares.
Hanall Biopharma Co., Ltd. has not announced a new split in our records. Its most recent split was on May 24, 2006, 20 years ago. Companies announce splits in advance, and any new KRX:009420 split will appear on this page.
Already premium?